| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.097 | 0.06 |